XML 94 R83.htm IDEA: XBRL DOCUMENT v3.25.2
Changes in Shareholders' Equity (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Feb. 21, 2025
Dec. 31, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance at start of the period $ 905,168,000 $ 948,947,000 $ 973,565,000 $ 967,320,000 $ 948,947,000 $ 967,320,000    
Net income 9,332,000 17,349,000 24,720,000 27,369,000 26,681,000 52,089,000    
Compensation and benefits paid or payable in shares 243,000 2,651,000 2,530,000 810,000        
Shares issued to Directors' 760,000   903,000          
Purchase of Treasury shares (51,295,000) (69,153,000)            
Dividends paid to noncontrolling interests   (88,000)            
Cumulative translation adjustments 38,902,000 17,014,000 (17,653,000) (12,070,000)        
Pension and postretirement liability adjustments (855,000) (2,662,000) 246,000 382,000        
Derivative valuation adjustment and other (122,000) (628,000) (2,840,000) (2,124,000)        
Balance at end of the period $ 894,109,000 $ 905,168,000 $ 973,348,000 973,565,000 $ 894,109,000 $ 973,348,000    
Dividends declared on Class A Common Stock (in dollars per share) $ 0.27   $ 0.26   $ 0.54 $ 0.52    
Stock repurchase program, authorized amount             $ 250,000,000 $ 200,000,000
Common Class A                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Treasury stock, balance at the beginning of the period (in shares)   9,844,746     9,844,746      
Dividends declared on Class A and Class B Common Stock $ (8,024,000) $ (8,262,000) $ (8,123,000) $ (8,122,000)        
Treasury stock, balance at the end of the period (in shares) 11,515,604       11,515,604      
Dividends declared on Class A Common Stock (in dollars per share) $ 0.27 $ 0.27 $ 0.26 $ 0.26        
Common Stock | Common Class A                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock, balance at the beginning of the period (in shares) 40,973,000 40,917,000 40,898,000 40,856,000 40,917,000 40,856,000    
Balance at start of the period $ 41,000 $ 41,000 $ 41,000 $ 41,000 $ 41,000 $ 41,000    
Compensation and benefits paid or payable in shares (in shares)   56,000   42,000        
Shares issued to Directors' (in shares) 11,000   10,000          
Common stock, balance at the end of the period (in shares) 40,984,000 40,973,000 40,908,000 40,898,000 40,984,000 40,908,000    
Balance at end of the period $ 41,000 $ 41,000 $ 41,000 $ 41,000 $ 41,000 $ 41,000    
Additional paid-in capital                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance at start of the period 455,584,000 452,933,000 449,028,000 448,218,000 452,933,000 448,218,000    
Compensation and benefits paid or payable in shares 243,000 2,651,000 2,530,000 810,000        
Shares issued to Directors' 760,000   903,000          
Balance at end of the period 456,587,000 455,584,000 452,461,000 449,028,000 456,587,000 452,461,000    
Retained  earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance at start of the period 1,074,863,000 1,065,763,000 1,030,111,000 1,010,942,000 1,065,763,000 1,010,942,000    
Net income 9,183,000 17,355,000 24,624,000 27,291,000        
Derivative valuation adjustment and other   7,000            
Balance at end of the period 1,075,934,000 1,074,863,000 1,046,612,000 1,030,111,000 1,075,934,000 1,046,612,000    
Retained  earnings | Common Class A                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Dividends declared on Class A and Class B Common Stock (8,024,000) (8,262,000) (8,123,000) (8,122,000)        
Derivative valuation adjustment and other         (88,000)      
Accumulated items of other comprehensive income                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance at start of the period (182,150,000) (195,989,000) (147,026,000) (133,168,000) (195,989,000) (133,168,000)    
Cumulative translation adjustments 38,835,000 17,136,000 (17,287,000) (12,116,000)        
Pension and postretirement liability adjustments (855,000) (2,662,000) 246,000 382,000        
Derivative valuation adjustment and other (122,000) (635,000) (2,840,000) (2,124,000)        
Balance at end of the period (144,292,000) (182,150,000) (166,907,000) (147,026,000) (144,292,000) (166,907,000)    
Treasury Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance at start of the period $ (448,363,000) $ (379,210,000) $ (364,665,000) $ (364,665,000) $ (379,210,000) $ (364,665,000)    
Treasury stock, balance at the beginning of the period (in shares) 10,770,000 9,845,000 9,662,000 9,662,000 9,845,000 9,662,000    
Purchase of Treasury shares (in shares) 746,000 925,000     1,670,858      
Purchase of Treasury shares $ (51,295,000) $ (69,153,000)     $ (120,400,000)      
Balance at end of the period $ (499,658,000) $ (448,363,000) $ (364,665,000) $ (364,665,000) $ (499,658,000) $ (364,665,000)    
Treasury stock, balance at the end of the period (in shares) 11,516,000 10,770,000 9,662,000 9,662,000 11,516,000 9,662,000    
Noncontrolling Interest                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance at start of the period $ 5,193,000 $ 5,409,000 $ 6,076,000 $ 5,952,000 $ 5,409,000 $ 5,952,000    
Net income 149,000 (6,000) 96,000 78,000        
Dividends paid to noncontrolling interests   (88,000)            
Cumulative translation adjustments 67,000 (122,000) (366,000) 46,000        
Derivative valuation adjustment and other 88,000              
Balance at end of the period $ 5,497,000 $ 5,193,000 $ 5,806,000 $ 6,076,000 $ 5,497,000 $ 5,806,000